Welcome to CSUR Research and Consultancy.
We are CSUR, the research agency specializing in submitting applications for premarket tobacco product applications (PMTA) and modified risk tobacco products (MRTP)
Centre for Substance Use Research Ltd is a multi-disciplinary research agency providing behavioural science support to companies submitting applications for PMTA, MRTP and TPD approval.
What is PTMA?
In May 2016, the U.S. Food and Drug Administration (FDA), through its Center for Tobacco Products, finalized a rule – referred to as the ‘final deeming rule’ – that deemed all products meeting the statutory definition of “tobacco product” in section 70 201(rr) of the FD&C Act (21 U.S.C. 321(rr)) to be subject to chapter IX of the FD&C Act. The Centre for Substance Use Research (CSUR) is expert in the design, execution and reporting of the behavioral studies required by FDA in a PMTA.
You can find out more info here.
What is MRTP?
In order to list a tobacco product as a “Modified Risk Tobacco Product” manufactures/brands need to provide scientific evidence to substantiate their modified risk claims. If the application submitted is sufficient in providing substantial scientific evidence in support of the modified risk claims.
We offer a wide variety of services in order to allow you to reach your goals.
Areas of Research and expertise
Centre for Substance Use Research Ltd,
4 Woodside Terrace
Get in Touch
Get in touch with us today and arrange an appointment to speak to our team.
Since opening in 1994 CSUR has become one of the leading research centres providing behavioural science support to companies seeking regulatory approval for their ENDS products. CSUR is committed to undertaking rigorous, ethical, and impactful research to further the goal of reducing smoking related health harm
Dr Neil Mckeganey